Vimarsana
Biggest News Aggregation in the World

Page 4 - Ed Boyden News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ed Boyden. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ed Boyden Today - Breaking & Trending Today

ABRF 2023 ANNUAL MEETING, MAY 7-10, BOSTON - Vimarsana News

ABRF 2023 ANNUAL MEETING, MAY 7-10, BOSTON

/PRNewswire/ -- The Association of Biomolecular Resource Facilities (ABRF) 2023 Annual Meeting will be held May 7-10 at the Sheraton Boston Hotel. This year's...

Neuro Startup Cognito Corrals $73M as Alzheimer's Device Commences Key Test - Vimarsana News

Neuro Startup Cognito Corrals $73M as Alzheimer's Device Commences Key Test

Alzheimer’s disease research at MIT spawned Cognito Therapeutics, a startup whose medical device uses light and sound to modulate electrical activity that supports brain health. The company’s Series B financing will support a Phase 3 test of its technology in patients with mild-to-moderate disease.

Portraiture at the intersection of art, science, and society - Vimarsana News

Portraiture at the intersection of art, science, and society

Herlinde Koelbl's "Fascination of Science," a photography exhibit at MIT's Koch Institute, attempts to make visible the luminary personalities behind major scientific and engineering advances.

Source: mit.edu
First human trials test light & sound therapy for Alzheimer's disease - Vimarsana News

First human trials test light & sound therapy for Alzheimer's disease

A new study has reported on the first human tests of an experimental therapy using sound and light to treat Alzheimer's disease. The initial results are promising, with the treatment leading to some neurological and cognitive improvements.

Small studies of 40-hertz sensory stimulation confirm safety, suggest Alzheimer's benefits | MIT News - Vimarsana News

Small studies of 40-hertz sensory stimulation confirm safety, suggest Alzheimer's benefits | MIT News

Early-stage clinical studies testing the safety and efficacy of 40-hertz sensory stimulation to treat Alzheimer’s disease found that the potential therapy was well-tolerated and was associated with some significant neurological and behavioral benefits among a small cohort of participants.

Source: mit.edu